ArticleAnnals of internal medicine2020

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.

Antonios Douros et al.PubMed ↗Publisher ↗

No numbers read from the abstract.